Today (31 September) the European Commission confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines. The Commission announced a contribution of €400 million in guarantees to support COVAX and its objectives in the context of the Coronavirus Global Response. Ursula von der Leyen, President of the European Commission, said: “Global collaboration is the only way to overcome a global pandemic. Almost €16 billion have been pledged so far and the most talented researchers and organizations are pooling their efforts to deliver vaccines, tests and treatments, which will be our universal, common good.”